In vitro blood vessels as a model for anti-angiogenic drug response testing
2019
Wisconsin Institutes for Medical Research, University of Wisconsin, Madison, USA
A three-dimensional platform was created using tissue from healthy people and patients with kidney tumors, which reflects the blood supply to the tumors. In this way, the efficacy of anti-angiogenic therapies can be assessed for each an individual patient.
Patient-specific organotypic blood vessels as an in vitro model for anti-angiogenic drug response testing in renal cell carcinoma
David J. Beebe
Added on: 05-25-2020
[1] https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(19)30166-5/fulltext[2] https://www.technologynetworks.com/diagnostics/news/a-personalized-microfluidic-model-for-kidney-cancer-drug-screening-317706
